The prevalence and clinical significance of alexithymia in restless legs syndrome

Öz

Objectives: Alexithymia, characterised by difficulties in identifying and expressing emotions, has been associated with various neurological and psychiatric disorders, but its prevalence and clinical impact in Restless Legs Syndrome (RLS) remain insufficiently characterised. This study aimed to explore the relationship between alexithymia and RLS, with particular focus on the association between alexithymia and the perception and severity of RLS symptoms. Methods: This cross-sectional study was conducted with 81 RLS patients (24 males, 57 females; mean age 51.91 years). Alexithymia was assessed with the Toronto Alexithymia Scale-20 (TAS-20) and disease severity with the RLS Severity Rating Scale (RLS-SRS). Descriptive statistics and correlation analyses were applied. Results: Definite alexithymia (TAS-20 ≥ 61) was present in 54.3% of patients. No significant correlation was found between TAS-20 and RLS-SRS scores (r = 0.150; p = 0.182). Education level was the only variable significantly associated with TAS-20 scores (r = −0.451; p < 0.001). Gender and age had no significant effect on either alexithymia or RLS severity. Conclusion: Alexithymia is highly prevalent in RLS patients but does not correlate directly with symptom severity. These findings suggest that emotional processing difficulties represent a clinically significant but severity-independent burden in RLS. Incorporating alexithymia screening and psychological support into RLS management may warrant consideration, although this potential benefit should be confirmed in controlled, longitudinal studies before it can be recommended for routine practice.

Anahtar Kelimeler

• Restless Legs Syndrome
• Affective Symptoms
• Emotional Regulation
• Alexithymia

Huzursuz bacak sendromunda aleksitiminin prevalansı ve klinik önemi

Öz

Amaç: Duyguları tanımlama ve ifade etmede güçlükle karakterize bir durum olan aleksitimi, çeşitli nörolojik ve psikiyatrik bozukluklarla ilişkilendirilmiştir; ancak Huzursuz Bacak Sendromu'ndaki (HBS) prevalansı ve klinik etkisi yeterince aydınlatılmamıştır. Bu çalışma, aleksitimi ile HBS arasındaki ilişkiyi, özellikle aleksitiminin HBS semptomlarının algılanması ve şiddeti ile ilişkisine odaklanarak araştırmayı amaçlamıştır. Yöntem: Bu kesitsel çalışma, 81 HBS hastası (24 erkek, 57 kadın; ortalama yaş 51.91) ile yürütülmüştür. Aleksitimi, Toronto Aleksitimi Ölçeği-20 (TAS-20) ile; hastalık şiddeti ise HBS Şiddet Değerlendirme Ölçeği (HBS-ŞDÖ) ile değerlendirilmiştir. Tanımlayıcı istatistikler ve korelasyon analizleri uygulanmıştır. Bulgular: Kesin aleksitimi (TAS-20 ≥ 61) hastaların %54.3'ünde saptanmıştır. TAS-20 ile HBS-ŞDÖ puanları arasında anlamlı bir korelasyon bulunmamıştır (r = 0.150; p = 0.182). Eğitim düzeyi, TAS-20 puanlarıyla anlamlı ilişki gösteren tek değişken olarak saptanmıştır (r = −0.451; p < 0.001). Cinsiyet ve yaşın ne aleksitimi ne de HBS şiddeti üzerinde anlamlı bir etkisi bulunmamıştır. Sonuç: Aleksitimi, HBS hastalarında oldukça yaygındır ancak semptom şiddetiyle doğrudan ilişkili değildir. Bu bulgular, duygusal işleme güçlüklerinin HBS'de şiddetten bağımsız ancak klinik açıdan önemli bir yük oluşturduğunu düşündürmektedir. HBS yönetimine aleksitimi taramasının ve psikolojik desteğin dahil edilmesi değerlendirilebilir; ancak bu potansiyel yararın rutin uygulamaya önerilebilmesi için kontrol gruplu, ileriye dönük çalışmalarla doğrulanması gerekmektedir.

Anahtar Kelimeler

• Huzursuz Bacaklar Sendromu
• Duygusal Düzenleme
• Aleksitimi
• Affektif Semptomlar

Kaynakça

1. O'Keeffe ST. Restless legs syndrome. A review. Arch Intern Med 1996;156(3):243-8. 2. Antelmi E, Rocchi L, Latorre A, et al. Restless legs syndrome: known knowns and known unknowns. Brain Sci 2022;12(1):118.
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003;4(2):101-19.
3. Kaynak DK. Sleep disorders behind the complaint of insomnia; restless legs syndrome and periodic limb movements disorders of sleep. Noro Psikiyatr Ars 2007;44:95-100.
4. Goerlich-Dobre KS, Votinov M, Habel U, Pripfl J, Lamm C. Neuroanatomical profiles of alexithymia dimensions and subtypes. Hum Brain Mapp 2015;36(10):3805-18.
5. Frank MJ, Hutchison K. Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience 2009;164(1):131-40.
6. Lesser IM. A review of the alexithymia concept. Psychosom Med 1981;43(6):531-43.
7. Yilmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A. Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome. Neuropsychiatr Dis Treat 2018;14:2207-14.
8. Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Prevalence and characteristics of alexithymia in Parkinson's disease. Psychosomatics 2010;51(1):22-8.

9. Ucgun AB, Kilit TP, Onbasi K. The investigation of the frequency of restless leg syndrome and related factors in diabetic patients. Nobel Medicus 2019;15(1):28-32.
10. Carollo G, Quinci R, Mingolla GP, Sandri A, Tinazzi M, Antelmi E. Restless legs syndrome and impulsive decision-making: impact of symptom severity, chronotype and interoception. Mov Disord Clin Pract 2025;12(8):1066-74.
11. Alkaş D, Bacık Yaman G, Doğan Ünlü M, İşcan G, Eren İ. Alexithymia, anger, sensitivity to mild bodily sensations and personality characteristics of restless legs syndrome patients: a case-control study. Turk Psikiyatri Derg 2024;35(4):271-81.
12. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38(1):23-32.
13. Güleç H, Köse S, Güleç MY, et al. Reliability and factorial validity of the Turkish version of the 20-item Toronto Alexithymia Scale (TAS-20). Klinik Psikofarmakoloji Bülteni 2009;19(3):214-20.
14. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4(2):121-32.
15. Hening WA, Allen RP. Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Med 2003;4(2):95-7.
16. Lumley MA, Neely LC, Burger AJ. The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess 2007;89(3):230-46.
17. Sagar R, Talwar S, Desai G, Chaturvedi SK. Relationship between alexithymia and depression: a narrative review. Indian J Psychiatry 2021;63(2):127-33.
18. Winkelman JW, Gagnon A, Clair AG. Sensory symptoms in restless legs syndrome: the enigma of pain. Sleep Med 2013;14(10):934-42.
19. Milosavljevic B, Carter Leno V, Simonoff E, et al. Alexithymia in adolescents with autism spectrum disorder: its relationship to internalising difficulties, sensory modulation and social cognition. J Autism Dev Disord 2016;46(4):1354-67.
20. Ernst J, Böker H, Hättenschwiler J, et al. The association of interoceptive awareness and alexithymia with neurotransmitter concentrations in insula and anterior cingulate. Soc Cogn Affect Neurosci 2014;9(6):857-63.
21. Lyvers M, Duric N, Thorberg FA. Caffeine use and alexithymia in university students. J Psychoactive Drugs 2014;46(4):340-6.
22. Lane RD, Sechrest L, Riedel R. Sociodemographic correlates of alexithymia. Compr Psychiatry 1998;39(6):377-85.
23. Hogeveen J, Grafman J. Alexithymia. Handb Clin Neurol 2021;183:47-62.
24. Joukamaa M, Taanila A, Miettunen J, Karvonen JT, Koskinen M, Veijola J. Epidemiology of alexithymia among adolescents. J Psychosom Res 2007;63:373-6.
25. An T, Sun H, Yuan L, Wu X, Lu B. Associations of anxiety and depression with restless leg syndrome: a systematic review and meta-analysis. Front Neurol 2024;15:1366839.
26. Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2025;21(3):571-617.
27. Di Tella M, Castelli L. Alexithymia in chronic pain disorders. Curr Rheumatol Rep 2016;18(7):41.
28. Martínez MP, Sánchez AI, Miró E, Lami MJ, Prados G, Morales A. Relationships between physical symptoms, emotional distress, and pain appraisal in fibromyalgia: the moderator effect of alexithymia. J Psychol 2015;149(1-2):115-40.
29. Ceylan M, Aygül R, Yalçın A. Erzurum ili huzursuz bacak sendromu prevelansının araştırılması ve sosyodemografik özelliklerin incelenmesi. Çağdaş Tıp Dergisi 2019;9(1):48-54.
30. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003;61(11):1562-9.